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Abstract: To investigate the association between
I-ILA-ORB I alleles and post-streptococcal acute
glomerulonephritis (PSAGN), 32 children with
PSAGN and 380 healthy subjects from the same
locality were typed for ORB I alleles using
polymerase chain-reverse hybridization technique.
Patients with PSAGN have significantly increased
frequency of both ORB 1* 030 II (46.9 vs. 19.2% in
controls, P = 0.(0025) and DR BI * I 105 (31.1 vs.
15.6% in controls, P = 0.0(97). However, after
correction of P values, only the difference for ORB 1*
03011 remains significant (Pe = 0.(25). Their relative
risks arc significantly high 13.71, confidence interval
(Cl) = 1.8-7.8, and 3.57, Cl = 1.4-8.9 respectively].
No significant differences in the frequency of both
alleles arc observed among patients with different
grades of hypertension, proteinuria or hematuria.
Conclusions: DRB 1* 030 I I, and presumably I 105,
alleles confer susceptibility to PSAGN. Ilowever the
severity of the disease is not determined by these two
alleles.
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Introduction
Post - streptococcal acute glomerulonephritis
(PSAGN) is a non-suppurative sequaele of infection
by P -hemolytic streptococci. It is accepted that the
immune response of the host is the central
pathogen tic event in the development of PSAGN [I)
and the antibody response to streptococcal antigens
is under genetic control [2). Many researches have
studied the association of PSAGN and serologicaly
typed HLA antigens 13-5). However, no consistent
association has been found.
HLA class II antigens (DR, DQ, and DP) are
hetrodimeric glycoprotcins consisting of CX and p
chains. The genes coding for these antigens are
located on the short arm of chromosome 6 16].
HLA-DR has one gene coding for the DR cx chain,
ORA, and one gene coding for the P chain, ORB.
Depending on the ORB type, ORB I is always
present, a DRB3, DRB4 or ORBS gene may be
present as well, eventually accompanied by
pseudogenes 17]. ORA is not polymorphic, while
ORB I is highly polymorphic, and some
polymorphism is described in DRB3, DRB4. and
ORBS.
All these genes consist of 7 exons. Most of the
allelic polymorphism is located in exon 2, encoding
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the amino-terminal extracellular domain functions as
the antigen binding site for processed proteins.
This high polymorphism of DRB I genes makes them
powerful markers for population genetic studies [8].
Since DRB 1 typing by molecular genetic techniques
declares more specific association with diseases and
no reports describe DRBl alleles association in
children with PSAGN in our population, we decided
to study this association using DNA-polymerase
chain-reverse hybridization technique.
Subjects
Thirty-two patients with PSAGN were included: 12
males, 20 females, aged 4-10 years. The diagnosis of
PSAGN depends on the presence of hematuria,
transient hypocomplementemia, and evidence of
preceding streptococcal infection. The severity of
hypertension was assessed according the task force on
blood pressure in children [91. Twenty-one patients
had severe hypertension, 7 patients had non-severe,
while 4 patients had normal blood pressure.
Hematuria was microscopic in 18 patients and
macroscopic in 14 patients. Twenty patients had
nephrotic proteinuria (more than Ig/m2/d) while 12
patients had non-nephrotic range proteinuria. Patients
were recruited from Division of Pediatric Nephrology,
Mansoura Faculty of Medicine, Mansoura. Egypt
from December 1996 to July 1997. The study was
approved by the ethics committee of Mansoura
Faculty of Medicine. Informed consent was obtained
from the parents.
HLA class 1/ alleles typing: Patients and controls were
typed for ORB I alleles by using INNO-LiPA, reverse
hybridization line probe assay (Innogenetics. N.V.
Belgium). The INNO-LiPA HLA typing tests arc
based on the reverse hybridization principle [10, II].
DNA is at first extracted from the test sample, then
amplified using polymerase chain reaction (PCR)
[12]. The amplified biotinylated DNA material is
chemically denatured, and the single strands arc
hybridized with specific oligonucleotide probes
immobilized as parallel lines on membrane-based
strips. After hybridization, streptavidin labeled with
alkaline phosphatase is added and bound to any
biotinylated hybrid previously formed. Incubation
with chromogen results in purple brown precipitate.
The reaction is stopped by a wash step and the
reactivity pattern of the probes is recorded. The site
and the molecular weight of the hybridized probe
define a certain allele.
Statistical analyses: The results of HLA typing were
compared to 380 unrelated healthy controls These
subjects included persons coming to the hospital for
minor surgical problems and parents of the children
attending the pediatric outpatient clinic. SPSS
computer package (release 5.0.2) was used for
statistical analysis. The significance of association
was tested using the X 2 with continuity correction or
two-tail Fisher's exact test. P values were corrected
(Pe) by multiplying by the number of alleles tested
(99 alleles).
The relative risk (RR) was calculated by Odd's
ratio. The significance of RR was tested by total X 2
lI3]. Multiple X 2 = Wy2, where Y = Log eRR, and
W = II( Ilh + Ilk + IIH + IlK). Where h is the
number of patients having the antigen, k is number
of patients lacking this antigen. H is the number of
controls having the antigens and K is the number of
controls lacking it. The etiologic fraction (EF) was
calculated by the formula of Bengsson and Tomson.
EF = (FAD - FAP) I (I - FAP), where FAD denotes
the frequency of the antigen in individuals with the
disease, FAP is the frequency of the antigen in
general population r 141.
Results
Table I shows that patients with PSAGN have
increased frequency of ORB I *030 II allele (46.9 vs
19.2% in controls, P=O.0002, Pc=0.025). RR is high
(3.71; cr= 1.8-7.8) and signi ficant (table 2).
EF is high (0.34). Although the frequency of ORB I *
1105 is higher in patients with PSAGN (31.1 vs
15.6~ in controls, P= 0.0097), this frequency
becomes non-significant when P value was
corrected to the number of alleles tested. Ilowever
its RR is still high (3.57; CI= 1.4-8.9) and
signi ficant (table 2).
Table 3 shows that patients with different grades of
hypertension have no difference in the frequency of
both ORBI* 03011 and 1105. Patients with
111 icrcseopie or macroscopic hematuria have si 111 i lar
frequency of both ORB I * 030 I I and I 105 (Fig. I).
Similarly, no difference in the frequency of these
two alleles between patients with different grades of
proteinuria (Fig. I).
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Table I. ORB 1* allele frequencies in patients with poststreptococcal acute glomerulonephritis and controls
Alle!e Paliel/IS (1/= 32) Controls (11= 380) P Pc 95% Cl EF
N % n %
RR
DRBI* 1601 I 3.1 9 2.4
DRBI* 16020 I 3.1 4 1.1
DRBI* 03011 15 46.9 73 19.2
ORB I * 0302 3 9.4 12 3.2
DRBI*0401 I 3.1 4 1.1
ORB 1*0402 6 18.8 36 9.5
ORB I * 0404 3.1 21 5.5
ORB I * 0405 I 3.1 17 4.5
DRBI' 0412 2 6.3 2 0.5
DRBI'0417 2 6.3 I 0.3
DRBI*IIOII 3.1 65 17.1
DRBI'1417 I 3.1 2 0.5
DRBI* 0701 6 18.8 67 17.6
DRBI*09011 3 9.4 9 2.9
DRBI* 1105 8 31.1 21 15.6
DRBI*1106 3.1 2 0.5
DRBI* 1107 3.1 8 2
DRBI* 1201 I 3.1 5 1.3
DRBI' 1301 3 9.4 50 13.2
DRBI' 1303 4 12.5 24 6.3
DRBI' 1309 2 6.3 3 0.8
0.00025 1.8-7.8 0.340.025 3.71
0.0097 1.4-8.9 0.180.96 3.57
Table 2. The significance or association of PSAGN and ORB I alleles
Pe P corrected RR Relative risk Cl Confendeuce interval EF etiologic fraction
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Table 3. Frequency or I)R!3 I • 03() I I und I 105 allele, ill patiellts with di Herent grades of hypertension
II\' iertension
I)R!3 1* ()JO!I Severe Non-severe Absent TOla!
+ II 4 0 15
10 3 4 17
Total 21 7 4 32
P=0.13
II)' iertension




































Fig. 1. ORB 1* 03011 & 1105 frequencies in patients with different
grades of proteinuria and hematuria
Discussion
In this study, we demonstrated a significant
association, tested by RR, of PSAGN with ORB I *
030 Il and I 105 al leles. The insignificantly higher
frequency of ORB I * I 105 when P value was
corrected for the number of alleles tested may be due
to the small number of patients included in the study.
Well in 18I 2 [15] was the first one who suspected the
familial predisposition to PSAGN. He observed that
the siblings of the child who developed nephritis after
scarlet fever were much more likely to develop
nephritis than the siblings of children who developed
scarlet fever without nephritis. Sasazuki et al. in 1983
[16] assumed that patients with PSAGN are
genetically programmed to respond abnormally to
streptococcal infection. Recently it is proposed that
streptococcal M proteins and pyrogenic exotoxins can
act as superantigens that cause a marked expansion of
T cells expressing specific T-cell receptor ~ -chain
variable gene segments [17-191. Jt is generally agreed
that HLA II alleles playa central role in recognition
of antigens by T -cells [201. The association of
PSAGN and ORB 1* 03011 and 1105 alleles, may be
due to the direct influence of these alleles on the
immune system predisposing children to PSAGN.
However, this association may result from the effect
of non-Hl.A genes in linkage disequilibrium with one
or more of these alleles [21].
Many studies were done on the association of PSAGN
with HLA class II. The results, however, do not point
to a universal marker of the disease. Read et al.
showed no HLA association of the disease in East
Indian patients [31. Significant association with DR4
in had been reported from Venezuela [4]. Sasazuki et
al. reported that Japanese patients with PSAGN have
increased frequency of DR w 13-Dw 19 haplotype [51.
This haplotype corresponds to HLA-ORB I * 1302-
OQA I * 0 I02-DQB 1* 0604 [22J. However, Mori et
al. [231 reported an association of DPB I * 050 I with
patients with PSAGN in Japan with no differences
in the frequencies of ORB I or DQB I between
patients and controls. This discrepancy may be
explained by the difference in HLA distribution
among different population.
The absence of difference in the frequency of
DRBI* 03011 and 1105 between. patients with
different grades of the disease points to the
insignificant role of these alleles in affecting the
severity of the disease. Reported association of HLA
class " alleles with the severity of the disease had
been reported with haplotypes rather than with
alleles, there are even fewer data from experimental
studies to help interpretation of these results [241.
We conclude that ORB I * 030 I I and/or I 105 might
be a restricting clement in the presentation of
disease-causing streptococcal antigenic peptide.
However they do not affect the severity of the
disease.
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